2m 2m 2m 2m 2m 2m 2m
KAIROS PHARMA (KAPA)
NYSE
$0.30-$0.003 (-1.01%)
Price as of Aug 03, 2026 11:32 AM EDT- $6.6MMarket Cap
- -66.71%1-Year Change
- BiotechnologyIndustry
KAIROS PHARMA (KAPA)
$0.30-$0.003 (-1.01%)
KAPA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.31 | ||
Change | +$0.006 (+2.07%) | ||
Open | $0.32 | ||
High | $0.33 | ||
Low | $0.29 | ||
Previous Close | $0.30 | ||
Volume | 2,421,873 | ||
30-Day Average Volume | 5,683,294 | ||
1-Week Change | 7.40% | ||
1-Month Change | -20.22% | ||
1-Year Change | -66.71% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 21.4M | ||
Total Assets | $5.7M | ||
Market Cap | $6.6M | ||
Enterprise Value | $2.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.2M | ||
EBIT | $0.00 | ||
EBITDA | $40,000.00 | ||
Net Working Capital | $4.0M | ||
EPS | -$0.08 | ||
Enterprise Value/EBITDA | 72 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | N/A | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue